Joshua O. Ojwang

1.7k total citations
21 papers, 996 citations indexed

About

Joshua O. Ojwang is a scholar working on Molecular Biology, Infectious Diseases and Virology. According to data from OpenAlex, Joshua O. Ojwang has authored 21 papers receiving a total of 996 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Infectious Diseases and 5 papers in Virology. Recurrent topics in Joshua O. Ojwang's work include HIV Research and Treatment (5 papers), HIV/AIDS drug development and treatment (5 papers) and RNA Interference and Gene Delivery (4 papers). Joshua O. Ojwang is often cited by papers focused on HIV Research and Treatment (5 papers), HIV/AIDS drug development and treatment (5 papers) and RNA Interference and Gene Delivery (4 papers). Joshua O. Ojwang collaborates with scholars based in United States, Belgium and Canada. Joshua O. Ojwang's co-authors include Robert F. Rando, Paul A. Cossum, Irina V. Lebedeva, C.A. Stein, Michael E. Hogan, John B. Harley, Thomas L. Wallace, J.W. Cavett, Adrien Székely and Kim L. Nguyen and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Biochemistry.

In The Last Decade

Joshua O. Ojwang

20 papers receiving 947 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joshua O. Ojwang United States 14 631 263 176 170 114 21 996
W. Thomas Mueller United States 13 504 0.8× 140 0.5× 241 1.4× 140 0.8× 179 1.6× 17 965
D. H. RICH United States 9 816 1.3× 175 0.7× 144 0.8× 187 1.1× 250 2.2× 11 1.2k
Thomas C. Warren United States 19 579 0.9× 304 1.2× 275 1.6× 111 0.7× 151 1.3× 27 1.3k
Himadri Samanta United States 19 676 1.1× 298 1.1× 268 1.5× 63 0.4× 393 3.4× 35 1.2k
Harold H.J. Backus Netherlands 17 595 0.9× 80 0.3× 101 0.6× 128 0.8× 72 0.6× 23 1.3k
Richard R. Gontarek United States 18 852 1.4× 102 0.4× 57 0.3× 117 0.7× 121 1.1× 25 1.3k
Dag E. Helland Norway 19 945 1.5× 138 0.5× 225 1.3× 149 0.9× 89 0.8× 50 1.2k
Manabu Taura Japan 20 420 0.7× 81 0.3× 89 0.5× 91 0.5× 340 3.0× 33 966
Huanzhang Zhu China 20 653 1.0× 450 1.7× 355 2.0× 54 0.3× 195 1.7× 45 1.3k
Jae Hoon Shim United States 19 697 1.1× 249 0.9× 97 0.6× 32 0.2× 32 0.3× 37 1.2k

Countries citing papers authored by Joshua O. Ojwang

Since Specialization
Citations

This map shows the geographic impact of Joshua O. Ojwang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joshua O. Ojwang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joshua O. Ojwang more than expected).

Fields of papers citing papers by Joshua O. Ojwang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joshua O. Ojwang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joshua O. Ojwang. The network helps show where Joshua O. Ojwang may publish in the future.

Co-authorship network of co-authors of Joshua O. Ojwang

This figure shows the co-authorship network connecting the top 25 collaborators of Joshua O. Ojwang. A scholar is included among the top collaborators of Joshua O. Ojwang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joshua O. Ojwang. Joshua O. Ojwang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rayan, Ghazi M., et al.. (2012). Monozygotic twins discordant for pediatric trigger-locked thumbs. Hand. 7(3). 320–322. 1 indexed citations
2.
Ojwang, Joshua O., et al.. (2012). Magnetically Vectored Platforms for The Targeted Delivery of Therapeutics to Tumors: History and Current Status. Nanomedicine. 7(2). 289–299. 14 indexed citations
3.
Dozmorov, Igor, Joel M. Guthridge, Kim L. Nguyen, et al.. (2010). Identification of Unique MicroRNA Signature Associated with Lupus Nephritis. PLoS ONE. 5(5). e10344–e10344. 175 indexed citations
4.
Ojwang, Joshua O., Indra Adrianto, Courtney Gray‐McGuire, et al.. (2010). Genome-Wide Association Scan of Dupuytren's Disease. The Journal Of Hand Surgery. 35(12). 2039–2045. 14 indexed citations
5.
Ojwang, Joshua O., Yan‐Hong Wang, Philip R. Wyde, et al.. (2005). A novel inhibitor of respiratory syncytial virus isolated from ethnobotanicals. Antiviral Research. 68(3). 163–172. 26 indexed citations
6.
Ojwang, Joshua O., Shoukath M. Ali, Donald F. Smee, et al.. (2005). Broad-spectrum inhibitor of viruses in the Flaviviridae family. Antiviral Research. 68(2). 49–55. 23 indexed citations
7.
Lebedeva, Irina V., Anthony J. Raffo, Robert F. Rando, et al.. (2001). CHEMOSENSITIZATION OF BLADDER CARCINOMA CELLS BY BCL-xL ANTISENSE OLIGONUCLEOTIDES. The Journal of Urology. 166(2). 461–469. 32 indexed citations
8.
Lebedeva, Irina V., Robert F. Rando, Joshua O. Ojwang, Paul A. Cossum, & C.A. Stein. (2000). Bcl-xL in prostate cancer cells: effects of overexpression and down-regulation on chemosensitivity.. PubMed. 60(21). 6052–60. 149 indexed citations
9.
10.
Johnson, Elizabeth M., Joshua O. Ojwang, Adrien Székely, Thomas L. Wallace, & David W. Warnock. (1998). Comparison of In Vitro Antifungal Activities of Free and Liposome-Encapsulated Nystatin with Those of Four Amphotericin B Formulations. Antimicrobial Agents and Chemotherapy. 42(6). 1412–1416. 96 indexed citations
11.
Wasan, Kishor M., Manisha Ramaswamy, Samson Ng, et al.. (1998). Differences in the Lipoprotein Distribution of Free and Liposome-Associated All- trans -Retinoic Acid in Human, Dog, and Rat Plasma Are Due to Variations in Lipoprotein Lipid and Protein Content. Antimicrobial Agents and Chemotherapy. 42(7). 1646–1653. 10 indexed citations
12.
Cherepanov, Peter, José A. Esté, Robert F. Rando, et al.. (1997). Mode of Interaction of G-Quartets with the Integrase of Human Immunodeficiency Virus Type 1. Molecular Pharmacology. 52(5). 771–780. 70 indexed citations
13.
Ojwang, Joshua O., T. Sudhakar Rao, Nilabh Chaudhary, et al.. (1997). Inhibition of Tumor Necrosis Factor Alpha (TNFα) Expression and FunctionIn Vitroby Modified Antisense Oligonucleotides. Nucleosides and Nucleotides. 16(7-9). 1703–1707. 1 indexed citations
14.
Rao, T. Sudhakar, et al.. (1997). Synthesis of certain alkenyl purines and purine analogs as inhibitors of tumor necrosis factor alpha (TNFα). Journal of Heterocyclic Chemistry. 34(1). 257–262. 4 indexed citations
15.
Mazumder, Abhijit, Nouri Neamati, Joshua O. Ojwang, et al.. (1996). Inhibition of the Human Immunodeficiency Virus Type 1 Integrase by Guanosine Quartet Structures. Biochemistry. 35(43). 13762–13771. 109 indexed citations
16.
Ojwang, Joshua O., et al.. (1996). Intramolecular G-quartet Motifs Confer Nuclease Resistance to a Potent Anti-HIV Oligonucleotide. Journal of Biological Chemistry. 271(10). 5698–5703. 99 indexed citations
17.
Rando, Robert F., et al.. (1995). Suppression of Human Immunodeficiency Virus Type 1 Activity in Vitro by Oligonucleotides Which Form Intramolecular Tetrads. Journal of Biological Chemistry. 270(4). 1754–1760. 106 indexed citations
18.
Ojwang, Joshua O., et al.. (1995). Synthesis and Anti-DNA Viral Activities in Vitro of Certain 2,4-Disubstituted- 7-(2-deoxy-2-fluoro-.beta.-D-arabinofuranosyl)pyrrolo[2,3-d]pyrimidine Nucleosides. Journal of Medicinal Chemistry. 38(20). 3957–3966. 22 indexed citations
19.
Fennewald, Susan M., et al.. (1995). Inhibition of herpes simplex virus in culture by oligonucleotides composed entirely of deoxyguanosine and thymidine. Antiviral Research. 26(1). 37–54. 25 indexed citations
20.
Ojwang, Joshua O., et al.. (1994). Inhibition of Friend Murine Leukemia Virus activity by guanosine/thymidine oligonucleotides. Antiviral Research. 25(1). 27–41. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W. Thomas Mueller Breakdown of academic impact, for papers by D. H. RICH Breakdown of academic impact, for papers by Thomas C. Warren Breakdown of academic impact, for papers by Himadri Samanta Breakdown of academic impact, for papers by Harold H.J. Backus Breakdown of academic impact, for papers by Richard R. Gontarek Breakdown of academic impact, for papers by Dag E. Helland Breakdown of academic impact, for papers by Manabu Taura Breakdown of academic impact, for papers by Huanzhang Zhu Breakdown of academic impact, for papers by Jae Hoon Shim
Rankless by CCL
2026